20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with sq-23377 in 1 studies
| Studies (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Trials (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Recent Studies (post-2010) (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Studies (sq-23377) | Trials (sq-23377) | Recent Studies (post-2010) (sq-23377) |
|---|---|---|---|---|---|
| 640 | 13 | 233 | 4,385 | 10 | 493 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Didion, SP; Falck, JR; Fan, F; Maier, KG; Pabbidi, MR; Roman, RJ; Sun, CW; Williams, JM; Zhuo, J | 1 |
1 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and sq-23377
| Article | Year |
|---|---|
20-Hydroxyeicosatetraenoic acid contributes to the inhibition of K+ channel activity and vasoconstrictor response to angiotensin II in rat renal microvessels.
Topics: Angiotensin II; Animals; Calcium; Gene Expression; Hydroxyeicosatetraenoic Acids; Ionomycin; Male; Microvessels; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phospholipases A2; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Calcium-Activated; Rats; Receptors, Angiotensin; Renal Circulation; Type C Phospholipases; Vasoconstrictor Agents | 2013 |